TY  - JOUR
AU  - Alcántara Carrió, María Del Pino
AU  - Hanlon, Alexandra 
AU  - Buyyounouski, Mark 
AU  - Horwitz, Eric 
AU  - Pollack, Alan 
PY  - 2006
DO  - 10.1002/cncr.22341
SN  - 0008-543X
UR  - https://hdl.handle.net/20.500.14352/100415
T2  - Cancer
AB  - BACKGROUND. The nadir prostate-specific antigen (PSA) at 1 year (nPSA12) was investigated as an early estimate of biochemical and clinical outcome after radiotherapy (RT) alone for localized prostate cancer.METHODS.From May 1989 to November 1999, 1000...
LA  - eng
M2  - 41
PB  - American Cancer Society
KW  - Prostate cancer
KW  - Prostate-specific antigen nadir
KW  - 3D conformal radiotherapy
KW  - Distant metastasis
KW  - Cause-specific mortality
TI  - Prostate‐specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death
TY  - journal article
VL  - 109
ER  -